Advertisement

Topics

Novartis reports Phase lllb positive data of Cosentyx vs Stelara

19:00 EST 16 Jan 2018 | Net Resources International

Novartis has reported positive results from a Phase lllb trial evaluating Cosentyx (secukinumab) in comparison with Stelara (ustekinumab) for the...
Read More...

The post Novartis reports Phase lllb positive data of Cosentyx vs Stelara appeared first on Drug Development Technology.

Original Article: Novartis reports Phase lllb positive data of Cosentyx vs Stelara

NEXT ARTICLE

More From BioPortfolio on "Novartis reports Phase lllb positive data of Cosentyx vs Stelara"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...